Ingenia Therapeutics

Ingenia Therapeutics

  • Founded: 2019
  • Location: Watertown, MA
  • Employee range: 1 - 10
  • Clinical stage: Clin0
  • Therapy area: DME
  • Drug types: OPH, GER
  • Lead product: IGT-427
  • Product link:
  • Funding: <10M

job board

Short description:

Antibody Therapies

Drug notes:

Also Clin0 wet AMD; IGT-302 Clin0 glaucoma

Long description:

INGENIA Therapeutics is developing durable best-in-class therapeutic antibodies, restoring dysfunctional microvessels into their healthy state in multiple ophthalmic and systemic diseases. The company's unique science is based on its proprietary platform for the discovery and development of novel antibodies that target specific proteins involved in the regulation of microvascular function. INGENIA Therapeutics' lead product candidate is a monoclonal antibody that targets a key protein involved in the development of diabetic retinopathy, a leading cause of blindness.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy